Pricing Log in Create free account

Femasys Inc. (FEMY) vs GlucoTrack, Inc. (GCTK)

Femasys Inc. and GlucoTrack, Inc. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $14.5M against $840.0K — 17.3× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −534.3%) and the higher return on invested capital (0.00% vs −176.9%). Across the 17 metrics below, Femasys Inc. leads on 9 and GlucoTrack, Inc. on 8.

Valuation

Metric FEMY GCTK Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 2.41 1.17 2.52
P/B 1.37 n/m 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 3.35 5.10 2.88
Earnings yield (213.94%) (18,853.56%) (2.67%)
Free cash flow yield (326.31%) (6,690.23%) 0.09%

Profitability

Metric FEMY GCTK Medical Instruments & Supplies median
Gross margin 60.95% 0.00% 54.29%
Operating margin (763.90%) 0.00% 1.07%
Net margin (534.27%) 0.00% (1.61%)
Free cash flow margin (786.02%) 0.00% 1.08%
Return on equity (443.65%) (620.63%) (1.32%)
Return on assets (94.25%) (272.48%) 0.00%
Return on invested capital (176.91%) 0.00% 0.00%

Growth

Metric FEMY GCTK Medical Instruments & Supplies median
Revenue growth (TTM) 21.85% (60.61%) 8.85%
EPS growth (last fiscal year) 44.71% 99.24% 8.65%
Revenue growth, 5-year CAGR 17.18% 28.31% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FEMY GCTK Medical Instruments & Supplies median
Debt to equity 0.90 (1.11) 0.10
Current ratio 2.14 0.46 2.48
Net debt to EBITDA 0.23 0.25 0.89

Dividend

Metric FEMY GCTK Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric FEMY GCTK Medical Instruments & Supplies median
Market cap 14.54m 840.00k 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack